Brief: Medicenna Reports Q3 2023 Financial Results And Operational Highlights

Medicenna Therapeutics

07/02/2023 12:13

Feb 7 (Reuters) - Medicenna Therapeutics Corp  MDNA.TO :
    * MEDICENNA REPORTS THIRD QUARTER FISCAL 2023 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * EXPECTED CASH RUNWAY THROUGH COMPLETION OF ABILITY STUDY
AND
THROUGH CALENDAR Q2 2024
    * NET LOSS FOR QUARTER ENDED DECEMBER 31, 2022, WAS $1.1
MILLION,
OR $0.02 PER SHARE
    * Q3 EARNINGS PER SHARE VIEW C$-0.09 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX1GHJVS 
Further company coverage:  MDNA.TO 
 ((Reuters.Briefs@thomsonreuters.com;))